Nicholas Stephen Amoroso, MD , FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: JenaValve(SIGNIFICANT), Edwards Lifesciences(MODEST), Abbott Laboratories(MODEST), VDyne(MODEST), EastEnd Medical(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Nininger Medical(NONE) OTHER FINANCIAL BENEFIT: Egnite (NONE)

View Full Disclosure